Search Results for: "plos one"

Caught Our Notice: Another retraction for researcher paid $100k to leave uni

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, just shy of … Continue reading Caught Our Notice: Another retraction for researcher paid $100k to leave uni

Weekend reads: Systemic fraud in China; science without journals; authorship rules decay

The week at Retraction Watch featured the retraction of a paper that had been called “anti-vaccine pseudoscience,” a retraction following threats of violence against an editor, and an editorial board member’s resignation over how a journal handled a case of plagiarism. Here’s what was happening elsewhere:

Weekend reads: Why critics criticize; a Big Bang Theory retraction; Nobels under scrutiny

The week at Retraction Watch featured admissions of fake data from a biotech company whose compound is now in clinical trials, a look at who recycles text, and the apparent demotion of a researcher who had a paper on video games retracted. Here’s what was happening elsewhere:

ORI finds misconduct in case of biologist paid $100K by university to leave

A biologist who studied the impact of diabetes on the eye inappropriately altered data in five images from three papers, according to a new finding of misconduct issued by the U.S. Office of Research Integrity (ORI). Readers may be familiar with the subject of the findings: Azza El-Remessy, a former tenured associate professor at the … Continue reading ORI finds misconduct in case of biologist paid $100K by university to leave

Weekend reads: Preprints under scrutiny; a math retraction in politics; proving yourself wrong

The week at Retraction Watch featured a look at retractions in China, and an expression of concern for a paper co-authored by a controversial journalist in Australia. Here’s what was happening elsewhere:

When is a citation not enough?

Last year, Boris Ratnikov was reading a paper and saw a familiar image. He quickly realized: The image was from a 2012 paper he’d written, but wasn’t cited. The 2016 Cell Metabolism paper he was reading had copied a figure from his 2012 PLOS ONE paper without referencing it.  In September 2016, Ratnikov, who is … Continue reading When is a citation not enough?

Case closed? Fired Pfizer researcher slated for seven retractions

Pfizer has discovered two additional papers that merit retraction from the lab of a former employee. One of the papers, published in Clinical Cancer Research, was retracted earlier this month. Last year, Pfizer requested retractions of five papers from the lab of breast cancer researcher Min-Jean Yin, who was fired after an investigation revealed image duplication. … Continue reading Case closed? Fired Pfizer researcher slated for seven retractions

Weekend reads: An NIH grant scam; are calls for retraction useful?; how to end honorary authorship

The week at Retraction Watch featured the revocation of a PhD, a questionable way to boost university rankings, and a look at what editors should do when a researcher known to have committed misconduct submits a new manuscript. Here’s what was happening elsewhere:

The three-year delay: Journal finally retracts paper based on made-up data

Three years after an investigation revealed a 2013 paper was based on fraudulent data, a journal has finally retracted it. The paper, published in Journal of Hazardous Materials, was one of seven articles by a team at the Institute of Microbial Technology (IMTECH) in Chandigarh, India that contain fabricated data, according to an investigation by … Continue reading The three-year delay: Journal finally retracts paper based on made-up data

“The data have spoken:” Controversial NgAgo gene editing study retracted

The author of a 2016 paper describing a potentially invaluable lab tool has retracted it, following heavy criticism from outside groups that could not reproduce the findings. The paper had already been tagged with an Expression of Concern by the journal, Nature Biotechnology, which included data from multiple groups casting doubt on the original findings. Although … Continue reading “The data have spoken:” Controversial NgAgo gene editing study retracted